EU-OSHA has joined forces with the European Centre for Disease Prevention and Control (ECDC) to explore the use of rapid antigen diagnostic tests for SARS-CoV-2, the virus that causes COVID-19, in occupational settings.
The findings are presented in a new technical report, which includes a survey of EU-OSHA’s focal points on the use of rapid antigen tests in a workplace context. The report shows that rapid antigen testing can help to reduce the spread of the virus in high-risk indoor workplaces. However, the report stresses that testing cannot replace other safety and health measures and should be used to complement them.
It also highlights the importance of involving employers, workers, occupational safety and health authorities, public health authorities and occupational health services in the design of a testing strategy for the workplace before implementation.
Read the report: Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings